Buprenorphine: an overview for clinicians

Buprenorphine: an overview for clinicians

Collection:
Health Policy and Services Research
Series Title(s):
Issue brief (California HealthCare Foundation)
Author(s):
Steiger, Scott, author
DeFries, Triveni, author
Contributor(s):
California HealthCare Foundation, issuing body.
Publication:
[Oakland, California] : California Health Care Foundation, August 2019
Language(s):
English
Format:
Text
Subject(s):
Buprenorphine -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
California
United States
Genre(s):
Technical Report
Abstract:
Buprenorphine, an FDA-approved medication for addiction treatment and pain relief, cuts opioid overdose death rates in half. Yet nearly 80% of Americans with opioid use disorder (OUD) do not receive buprenorphine or other medication-assisted treatment (MAT). This document provides answers to frequently asked questions, aiming to increase prescriber comfort with prescribing buprenorphine throughout the health care system. Once the basics are mastered, buprenorphine can be as straightforward to prescribe as medications for other medical conditions.
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY-NC-ND license. (More information)
Extent:
1 online resource (1 PDF file (17 pages)).
NLM Unique ID:
101758687 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/101758687